The Objective of This Multicentre Study is to Collect Operative Data on the Related Clinical Functional Outcomes and Complications and of Market Approved Alcis Electrophysiology Catheters to Demonstrate Safety and Performance of These Devices in a Real-world Setting
EPICADIA - Electrophysiologic Performance Investigation for CArdiac DIAgnosis
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Sara Sitayeb
- Phone Number: +33 (0)3 81 61 54 16
- Email: ssitayeb@alcis.net
Study Contact Backup
- Name: Oualid Chabi
- Phone Number: +33 (0)3 81 61 54 14
- Email: ochabi@alcis.net
Study Locations
-
-
-
Avignon, France, 84000
- Clinique Rhône Durance
-
-
Ile De France
-
Créteil, Ile De France, France, 94000
- Hôpital Henri-Mondor AP-HP
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
To be included, patients must be:
- 18 to 90 years old
- Patient who have to undergo diagnostic procedure or ablation procedure (Cardiac arrythmias)
- Informed and willing to sign an informed consent for approved by EC
- Affiliation to the social security or foreign regime recognized in France
Exclusion Criteria:
A patient will not be eligible to participate in the study if any of the following conditions are present:
- Not able to comply with the study procedures based on the judgment of the assessor (e.g. cannot comprehend study questions, inability to keep scheduled assessment times).
- Any medical condition that could impact the study at investigator's discretion (e.g. allergy…).
- Pregnant women
- Adult subject to legal protection measure
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Signal quality
Time Frame: Through study completion, an average of 4 hours
|
Good signal amplitude and signal stability throughout the procedure without artefact
|
Through study completion, an average of 4 hours
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Micro-stimulation
Time Frame: Through study completion, an average of 4 hours
|
Micro-stimulation worked well.
|
Through study completion, an average of 4 hours
|
|
Manoeuvrability
Time Frame: Through study completion, an average of 4 hours
|
Ease of positioning and manoeuvrability the catheter (access to the desired area)
|
Through study completion, an average of 4 hours
|
|
Bending
Time Frame: Through study completion, an average of 4 hours
|
Link between the wheel and the bending for dynamic Xtrem and bending stability
|
Through study completion, an average of 4 hours
|
|
Imaging
Time Frame: Through study completion, an average of 4 hours
|
Visibility via X ray or 3D navigation.
|
Through study completion, an average of 4 hours
|
|
Diagnosis
Time Frame: Through study completion, an average of 4 hours
|
Diagnosis efficiency
|
Through study completion, an average of 4 hours
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2045-CIP_v1_01Feb2022
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.